These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8403622)
21. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016 [TBL] [Abstract][Full Text] [Related]
22. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women. Moghissi KS Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849 [TBL] [Abstract][Full Text] [Related]
23. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Freeman EW; Sondheimer SJ; Rickels K Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648 [TBL] [Abstract][Full Text] [Related]
26. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis. Gargiulo AR; Hornstein MD Semin Reprod Endocrinol; 1997; 15(3):273-84. PubMed ID: 9383836 [TBL] [Abstract][Full Text] [Related]
28. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. Freeman EW; Rickels K; Sondheimer SJ; Polansky M JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258 [TBL] [Abstract][Full Text] [Related]
30. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. Wyatt KM; Dimmock PW; Ismail KM; Jones PW; O'Brien PM BJOG; 2004 Jun; 111(6):585-93. PubMed ID: 15198787 [TBL] [Abstract][Full Text] [Related]
31. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial. Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358 [TBL] [Abstract][Full Text] [Related]
32. Current approaches to optimizing the treatment of endometriosis in adolescents. Laufer MR Gynecol Obstet Invest; 2008; 66 Suppl 1():19-27. PubMed ID: 18936548 [TBL] [Abstract][Full Text] [Related]
34. [Premenstrual syndrome. PMS should be seen as an illness]. Hammarbäck S Vardfacket; 1991 Feb; 15(3):XXI-XXIV. PubMed ID: 2053406 [No Abstract] [Full Text] [Related]
36. Psychological aspects of premenstrual syndrome. Indusekhar R; Usman SB; O'Brien S Best Pract Res Clin Obstet Gynaecol; 2007 Apr; 21(2):207-20. PubMed ID: 17175199 [TBL] [Abstract][Full Text] [Related]
37. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone. Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912 [TBL] [Abstract][Full Text] [Related]
38. Pre-menstrual syndrome--are gonadotropins the cause of the condition? Coulson CJ Med Hypotheses; 1986 Mar; 19(3):243-55. PubMed ID: 3007949 [TBL] [Abstract][Full Text] [Related]
39. Endometriosis and the estrogen threshold theory. Relation to surgical and medical treatment. Barbieri RL J Reprod Med; 1998 Mar; 43(3 Suppl):287-92. PubMed ID: 9564663 [TBL] [Abstract][Full Text] [Related]
40. Luteal phase support for assisted reproduction cycles. van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]